FDA Expands Tamiflu’s Use To Include Very Young Children

The Food and Drug Administration Dec. 21, 2012, expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks who have shown flu symptoms for no longer than two days.

The drug is not approved to prevent flu infection in this population, the agency said. In addition, the safety and efficacy of Tamiflu to treat flu infection has not been established in children younger than two weeks old. Tamiflu is distributed in the United States by Genentech, a member of the Roche Group.

Tamiflu was approved in 1999 to treat adults infected with flu who have ...